Document is current
Any future updates will be listed below
-
Authors
Martínez-Pascual, David
Catalán, José M.
Lledó, Luís D.
Blanco-Ivorra, Andrea
García-Aracil, Nicolás
-
Funding
Funding for this research was provided by:
Ministerio de Universidades (FPU20/05137, PID2022-139957OB-I00, PID2019-108310RB-I00)
Agencia Estatal de Investigación (TED2021-130431B-I00, PLEC2022-009424)
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 27 November 2024
First Online: 31 January 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Hospital La Pedrera de Denia (HLP_35/2021, 9 March 2021). Informed consent was obtained from all the participants involved in the study.
: All participants gave written informed consent for the publication of the study.
: Nicolas Garcia-Aracil is founder and CEO of Innovative Devices for Rehabilitation and Assistance (iDRhA). The IP protecting the Rubidium technology is licensed to iDRhA.
